Literature DB >> 26416220

Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?

Zachary Bloomgarden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26416220     DOI： 10.1038/nrendo.2015.166

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Approaches to treatment 1: How is type 2 diabetes actually treated?

Authors:  Zachary T Bloomgarden
Journal:  J Diabetes       Date:  2015-11       Impact factor: 4.006

2.  Renal status among patients using metformin in a primary care setting.

Authors:  Laurence Kennedy; William H Herman
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

3.  Sodium-glucose cotransporter 2 inhibitors and renal function-2.

Authors:  Zachary Bloomgarden
Journal:  J Diabetes       Date:  2015-03-03       Impact factor: 4.006

Review 4.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Authors:  Silvio E Inzucchi; Kasia J Lipska; Helen Mayo; Clifford J Bailey; Darren K McGuire
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

5.  The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment.

Authors:  Amanda D Hyre; Caroline S Fox; Brad C Astor; Andrew J Cohen; Paul Muntner
Journal:  Am J Kidney Dis       Date:  2007-01       Impact factor: 8.860

6.  Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.

Authors:  Rémy Boussageon; Irène Supper; Theodora Bejan-Angoulvant; Nadir Kellou; Michel Cucherat; Jean-Pierre Boissel; Behrouz Kassai; Alain Moreau; François Gueyffier; Catherine Cornu
Journal:  PLoS Med       Date:  2012-04-10       Impact factor: 11.069

7.  Comparative effectiveness of incident oral antidiabetic drugs on kidney function.

Authors:  Adriana M Hung; Christianne L Roumie; Robert A Greevy; Xulei Liu; Carlos G Grijalva; Harvey J Murff; T Alp Ikizler; Marie R Griffin
Journal:  Kidney Int       Date:  2012-01-18       Impact factor: 10.612

8.  Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine.

Authors:  Delphine S Tuot; Feng Lin; Michael G Shlipak; Vanessa Grubbs; Chi-yuan Hsu; Jerry Yee; Vahakn Shahinian; Rajiv Saran; Sharon Saydah; Desmond E Williams; Neil R Powe
Journal:  Diabetes Care       Date:  2015-08-25       Impact factor: 19.112
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.